Post by Tiefenbacher Group

💡 Insights from CPHI & PMEC China 2026 🌏 Last week, our colleagues Esra Yagsagan, Abel Keflai and Chaitanya S. attended CPHI & PMEC China in Shanghai, where discussions reflected both China’s continued importance in API sourcing and its growing role in pharmaceutical innovation. A key theme throughout the event was supply chain resilience. In a rapidly evolving global landscape, reliable partnerships and diversified supply networks remain essential to ensuring continued access to high-quality medicines. For Tiefenbacher Group, this aligns closely with our mission of improving patients’ lives through better therapies, better access and better affordability. Events like CPHI & PMEC China help us strengthen the partnerships and insights needed to turn that mission into reality.